Data Triumph at C

Publication date: 10 April 2017
Source:Cancer Cell, Volume 31, Issue 4
Author(s): Mark Levine, Pierre-Christian Violet
Despite historical controversy, pharmacologic ascorbate is emerging as promising cancer therapy via pro-oxidant chemistry. In this issue of Cancer Cell, Schoenfeld et al. describe how intracellular iron pools and reactive oxygen species drive pharmacologic ascorbate's selective toxicity to cancer cells in vitro, in mice, and in humans.

Teaser

Despite historical controversy, pharmacologic ascorbate is emerging as promising cancer therapy via pro-oxidant chemistry. In this issue of Cancer Cell, Schoenfeld et al. describe how intracellular iron pools and reactive oxygen species drive pharmacologic ascorbate's selective toxicity to cancer cells in vitro, in mice, and in humans.


from Cancer via ola Kala on Inoreader http://ift.tt/2p6SEj2
via IFTTT